The Current Ratio as of September 2024 (TTM) for Creative Medical Technology Holdings, Inc. (CELZ) is 20.21

According to Creative Medical Technology Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 20.21. This represents a change of -19.17% compared to the average of 25.00 of the last 4 quarters.

Creative Medical Technology Holdings, Inc. (CELZ) Historical Current Ratio (quarterly & annually)

How has CELZ Current Ratio performed in the past?

The mean historical Current Ratio of Creative Medical Technology Holdings, Inc. over the last ten years is 4.41. The current 20.21 Current Ratio has changed 45.72% with respect to the historical average. Over the past ten years (40 quarters), CELZ's Current Ratio was at its highest in in the June 2022 quarter at 58.88. The Current Ratio was at its lowest in in the March 2016 quarter at 0.00.

Creative Medical Technology Holdings, Inc. (CELZ) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Creative Medical Technology Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Creative Medical Technology Holdings, Inc. (CELZ) Average Current Ratio

How has CELZ Current Ratio performed in the past?

The current Current Ratio of Creative Medical Technology Holdings, Inc. (CELZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Creative Medical Technology Holdings, Inc. (CELZ) Current Ratio vs. Peers

How is CELZ’s Current Ratio compared to its peers?

Creative Medical Technology Holdings, Inc.’s Current Ratio is greater than Regen BioPharma, Inc. (0.03), greater than Theralink Technologies, Inc. (0.03), greater than Enzolytics Inc. (0.98), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than SeaStar Medical Holding Corporation (0.24), greater than Virios Therapeutics, Inc. (7.27), greater than ZyVersa Therapeutics, Inc. (0.06), greater than Revelation Biosciences, Inc. (1.10), greater than Palisade Bio, Inc. (4.31), greater than Quoin Pharmaceuticals, Ltd. (3.35), less than Virax Biolabs Group Limited (25.94), greater than Unicycive Therapeutics, Inc. (3.37), greater than Addex Therapeutics Ltd (0.71), greater than Aceragen, Inc. (0.83), greater than ERYTECH Pharma S.A. (0), greater than Soligenix, Inc. (1.52), greater than Avenue Therapeutics, Inc. (4.30), greater than Cardio Diagnostics Holdings, Inc. (5.69), greater than PaxMedica, Inc. Common Stock (2.40),

Build a custom stock screener for Creative Medical Technology Holdings, Inc. (CELZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Creative Medical Technology Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Creative Medical Technology Holdings, Inc. (CELZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Creative Medical Technology Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.